Table 3.

Associations Between Folate/Folic Acid Supplementation Status and Brain Structure (mm3)

Folate/Folic Acid Status
Folate/Folic Acid NonsupplementationFolate/Folic Acid Supplementation AloneFolate/Folic Acid Supplementation With Other B Vitamins
BetaBeta (95% CI)p ValueBeta (95% CI)p Value
Volume of gray matter (n = 40 142)
 Model 11 (ref)−1 496.90 (−4 649.78, 1 655.98).440721.31 (−3 795.50, 5 238.12).754
 Model 21 (ref)−1 113.77 (−4 234.00, 2 006.45).5491 044.90 (−3 471.96, 5 561.76).650
 Model 31 (ref)−691.80 (−3 803.26, 2 419.57).7211 272.00 (−3 230.47, 5 774.15).659
Volume of white matter (n = 40 142)
 Model 11 (ref)−3 657.83 (−7 050.18, −265.47).043*−2 378.72 (−7 238.60, 2 481.17).337
 Model 21 (ref)−3 472.41 (−6 866.02, −78.80).095−1 572.53 (−6 485.14, 3 340.09).751
 Model 31 (ref)−3491.51 (−6 886.44, −96.58).122−1 543.16 (−6 455.72, 3 369.39).708
Volume of white matter hyperintensities (n = 38 856)
 Model 11 (ref)658.24 (102.38, 1 214.09).025*−265.18 (−1 068.35, 537.98).518
 Model 21 (ref)669.83 (115.76, 1 223.90).038*−222.85 (−1 031.98, 586.28).668
 Model 31 (ref)548.10 (−2.36, 1 098.57).097−277.00 (−1 080.52, 526.52).564
Volume of hippocampus (n = 40 126)
 Model 11 (ref)−123.71 (−195.58, −51.83).001*52.60 (−50.37, 155.56).317
 Model 21 (ref)−117.92 (−189.70, −46.14).002*45.00 (−58.91, 148.90).481
 Model 31 (ref)−95.25 (−165.31, −25.19).014*48.67 (−52.70, 150.04).429
Volume of thalamus (n = 40 126)
 Model 11 (ref)−114.05 (−224.84, −3.26).055−12.71 (−171.43, 146.01).875
 Model 21 (ref)−101.50 (−211.52, 8.52).100−42.59 (−201.85, 116.67).680
 Model 31 (ref)−56.14 (−160.66, 48.37).362−33.85 (−185.09, 117.38).687
Volume of caudate (n = 40 126)
 Model 11 (ref)9.81 (−59.74, 79.35).78263.71 (−35.93, 163.34).263
 Model 21 (ref)12.48 (−56.88, 81.83).72445.85 (−54.55, 146.25).573
 Model 31 (ref)19.79 (−49.24, 88.81).67948.49 (−51.38, 148.37).522
Volume of putamen (n = 40 126)
 Model 11 (ref)−90.12 (−176.46, −3.78).051−22.56 (−146.25, 101.13).721
 Model 21 (ref)−83.25 (−169.32, 2.83).090−36.97 (−161.57, 87.63).596
 Model 31 (ref)−59.93 (−143.44, 23.58).255−32.68 (−153.51, 88.16).704
Volume of pallidum (n = 40 126)
 Model 11 (ref)−41.17 (−79.07, −3.28).041*17.65 (−36.63, 71.94).524
 Model 21 (ref)−39.85 (−77.67, −2.02).0669.83 (−44.92, 64.58).796
 Model 31 (ref)−29.90 (−67.25, 7.46).19012.68 (−41.37, 66.73).699
Volume of amygdala (n = 40 126)
 Model 11 (ref)−57.11 (−93.34, −20.88).003*−17.05 (−68.95, 34.86).520
 Model 21 (ref)−55.48 (−91.69, −19.27).005*−19.54 (−71.96, 32.87).608
 Model 31 (ref)−51.85 (−88.02, −15.68).012*−19.41 (−71.75, 32.92).578
Volume of accumbens (n = 40 126)
 Model 11 (ref)−24.77 (−41.11, −8.43).004*−4.71 (−28.11, 18.70).694
 Model 21 (ref)−22.35 (−38.67, −6.03).012*−2.21 (−25.83, 21.42).885
 Model 31 (ref)−15.78 (−31.33, −0.23).087−0.98 (−23.48, 21.52).932
Folate/Folic Acid Status
Folate/Folic Acid NonsupplementationFolate/Folic Acid Supplementation AloneFolate/Folic Acid Supplementation With Other B Vitamins
BetaBeta (95% CI)p ValueBeta (95% CI)p Value
Volume of gray matter (n = 40 142)
 Model 11 (ref)−1 496.90 (−4 649.78, 1 655.98).440721.31 (−3 795.50, 5 238.12).754
 Model 21 (ref)−1 113.77 (−4 234.00, 2 006.45).5491 044.90 (−3 471.96, 5 561.76).650
 Model 31 (ref)−691.80 (−3 803.26, 2 419.57).7211 272.00 (−3 230.47, 5 774.15).659
Volume of white matter (n = 40 142)
 Model 11 (ref)−3 657.83 (−7 050.18, −265.47).043*−2 378.72 (−7 238.60, 2 481.17).337
 Model 21 (ref)−3 472.41 (−6 866.02, −78.80).095−1 572.53 (−6 485.14, 3 340.09).751
 Model 31 (ref)−3491.51 (−6 886.44, −96.58).122−1 543.16 (−6 455.72, 3 369.39).708
Volume of white matter hyperintensities (n = 38 856)
 Model 11 (ref)658.24 (102.38, 1 214.09).025*−265.18 (−1 068.35, 537.98).518
 Model 21 (ref)669.83 (115.76, 1 223.90).038*−222.85 (−1 031.98, 586.28).668
 Model 31 (ref)548.10 (−2.36, 1 098.57).097−277.00 (−1 080.52, 526.52).564
Volume of hippocampus (n = 40 126)
 Model 11 (ref)−123.71 (−195.58, −51.83).001*52.60 (−50.37, 155.56).317
 Model 21 (ref)−117.92 (−189.70, −46.14).002*45.00 (−58.91, 148.90).481
 Model 31 (ref)−95.25 (−165.31, −25.19).014*48.67 (−52.70, 150.04).429
Volume of thalamus (n = 40 126)
 Model 11 (ref)−114.05 (−224.84, −3.26).055−12.71 (−171.43, 146.01).875
 Model 21 (ref)−101.50 (−211.52, 8.52).100−42.59 (−201.85, 116.67).680
 Model 31 (ref)−56.14 (−160.66, 48.37).362−33.85 (−185.09, 117.38).687
Volume of caudate (n = 40 126)
 Model 11 (ref)9.81 (−59.74, 79.35).78263.71 (−35.93, 163.34).263
 Model 21 (ref)12.48 (−56.88, 81.83).72445.85 (−54.55, 146.25).573
 Model 31 (ref)19.79 (−49.24, 88.81).67948.49 (−51.38, 148.37).522
Volume of putamen (n = 40 126)
 Model 11 (ref)−90.12 (−176.46, −3.78).051−22.56 (−146.25, 101.13).721
 Model 21 (ref)−83.25 (−169.32, 2.83).090−36.97 (−161.57, 87.63).596
 Model 31 (ref)−59.93 (−143.44, 23.58).255−32.68 (−153.51, 88.16).704
Volume of pallidum (n = 40 126)
 Model 11 (ref)−41.17 (−79.07, −3.28).041*17.65 (−36.63, 71.94).524
 Model 21 (ref)−39.85 (−77.67, −2.02).0669.83 (−44.92, 64.58).796
 Model 31 (ref)−29.90 (−67.25, 7.46).19012.68 (−41.37, 66.73).699
Volume of amygdala (n = 40 126)
 Model 11 (ref)−57.11 (−93.34, −20.88).003*−17.05 (−68.95, 34.86).520
 Model 21 (ref)−55.48 (−91.69, −19.27).005*−19.54 (−71.96, 32.87).608
 Model 31 (ref)−51.85 (−88.02, −15.68).012*−19.41 (−71.75, 32.92).578
Volume of accumbens (n = 40 126)
 Model 11 (ref)−24.77 (−41.11, −8.43).004*−4.71 (−28.11, 18.70).694
 Model 21 (ref)−22.35 (−38.67, −6.03).012*−2.21 (−25.83, 21.42).885
 Model 31 (ref)−15.78 (−31.33, −0.23).087−0.98 (−23.48, 21.52).932

Notes: BMI = body mass index; CI = confidence interval; CRP = C-reactive protein; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; TDI = Townsend deprivation index; TG = triglycerides. Model 1 was adjusted for age and sex. Model 2 additionally adjusted for BMI, TDI, education, ethnicity, assessment center, healthy diet, iron supplementation, smoking, and alcohol. Model 3 was based on Model 2 and additionally adjusted for the history of hypertension, cardiovascular disease, diabetes, stroke, and the levels of TG, HDL-C, LDL-C, and CRP. When assessing white matter hyperintensities and subcortical volumes, Model 3 additionally adjusted for the total intracranial volume (the sum of gray matter, white matter, and cerebrospinal fluid).

*Represent significant associations (p < .05).

Table 3.

Associations Between Folate/Folic Acid Supplementation Status and Brain Structure (mm3)

Folate/Folic Acid Status
Folate/Folic Acid NonsupplementationFolate/Folic Acid Supplementation AloneFolate/Folic Acid Supplementation With Other B Vitamins
BetaBeta (95% CI)p ValueBeta (95% CI)p Value
Volume of gray matter (n = 40 142)
 Model 11 (ref)−1 496.90 (−4 649.78, 1 655.98).440721.31 (−3 795.50, 5 238.12).754
 Model 21 (ref)−1 113.77 (−4 234.00, 2 006.45).5491 044.90 (−3 471.96, 5 561.76).650
 Model 31 (ref)−691.80 (−3 803.26, 2 419.57).7211 272.00 (−3 230.47, 5 774.15).659
Volume of white matter (n = 40 142)
 Model 11 (ref)−3 657.83 (−7 050.18, −265.47).043*−2 378.72 (−7 238.60, 2 481.17).337
 Model 21 (ref)−3 472.41 (−6 866.02, −78.80).095−1 572.53 (−6 485.14, 3 340.09).751
 Model 31 (ref)−3491.51 (−6 886.44, −96.58).122−1 543.16 (−6 455.72, 3 369.39).708
Volume of white matter hyperintensities (n = 38 856)
 Model 11 (ref)658.24 (102.38, 1 214.09).025*−265.18 (−1 068.35, 537.98).518
 Model 21 (ref)669.83 (115.76, 1 223.90).038*−222.85 (−1 031.98, 586.28).668
 Model 31 (ref)548.10 (−2.36, 1 098.57).097−277.00 (−1 080.52, 526.52).564
Volume of hippocampus (n = 40 126)
 Model 11 (ref)−123.71 (−195.58, −51.83).001*52.60 (−50.37, 155.56).317
 Model 21 (ref)−117.92 (−189.70, −46.14).002*45.00 (−58.91, 148.90).481
 Model 31 (ref)−95.25 (−165.31, −25.19).014*48.67 (−52.70, 150.04).429
Volume of thalamus (n = 40 126)
 Model 11 (ref)−114.05 (−224.84, −3.26).055−12.71 (−171.43, 146.01).875
 Model 21 (ref)−101.50 (−211.52, 8.52).100−42.59 (−201.85, 116.67).680
 Model 31 (ref)−56.14 (−160.66, 48.37).362−33.85 (−185.09, 117.38).687
Volume of caudate (n = 40 126)
 Model 11 (ref)9.81 (−59.74, 79.35).78263.71 (−35.93, 163.34).263
 Model 21 (ref)12.48 (−56.88, 81.83).72445.85 (−54.55, 146.25).573
 Model 31 (ref)19.79 (−49.24, 88.81).67948.49 (−51.38, 148.37).522
Volume of putamen (n = 40 126)
 Model 11 (ref)−90.12 (−176.46, −3.78).051−22.56 (−146.25, 101.13).721
 Model 21 (ref)−83.25 (−169.32, 2.83).090−36.97 (−161.57, 87.63).596
 Model 31 (ref)−59.93 (−143.44, 23.58).255−32.68 (−153.51, 88.16).704
Volume of pallidum (n = 40 126)
 Model 11 (ref)−41.17 (−79.07, −3.28).041*17.65 (−36.63, 71.94).524
 Model 21 (ref)−39.85 (−77.67, −2.02).0669.83 (−44.92, 64.58).796
 Model 31 (ref)−29.90 (−67.25, 7.46).19012.68 (−41.37, 66.73).699
Volume of amygdala (n = 40 126)
 Model 11 (ref)−57.11 (−93.34, −20.88).003*−17.05 (−68.95, 34.86).520
 Model 21 (ref)−55.48 (−91.69, −19.27).005*−19.54 (−71.96, 32.87).608
 Model 31 (ref)−51.85 (−88.02, −15.68).012*−19.41 (−71.75, 32.92).578
Volume of accumbens (n = 40 126)
 Model 11 (ref)−24.77 (−41.11, −8.43).004*−4.71 (−28.11, 18.70).694
 Model 21 (ref)−22.35 (−38.67, −6.03).012*−2.21 (−25.83, 21.42).885
 Model 31 (ref)−15.78 (−31.33, −0.23).087−0.98 (−23.48, 21.52).932
Folate/Folic Acid Status
Folate/Folic Acid NonsupplementationFolate/Folic Acid Supplementation AloneFolate/Folic Acid Supplementation With Other B Vitamins
BetaBeta (95% CI)p ValueBeta (95% CI)p Value
Volume of gray matter (n = 40 142)
 Model 11 (ref)−1 496.90 (−4 649.78, 1 655.98).440721.31 (−3 795.50, 5 238.12).754
 Model 21 (ref)−1 113.77 (−4 234.00, 2 006.45).5491 044.90 (−3 471.96, 5 561.76).650
 Model 31 (ref)−691.80 (−3 803.26, 2 419.57).7211 272.00 (−3 230.47, 5 774.15).659
Volume of white matter (n = 40 142)
 Model 11 (ref)−3 657.83 (−7 050.18, −265.47).043*−2 378.72 (−7 238.60, 2 481.17).337
 Model 21 (ref)−3 472.41 (−6 866.02, −78.80).095−1 572.53 (−6 485.14, 3 340.09).751
 Model 31 (ref)−3491.51 (−6 886.44, −96.58).122−1 543.16 (−6 455.72, 3 369.39).708
Volume of white matter hyperintensities (n = 38 856)
 Model 11 (ref)658.24 (102.38, 1 214.09).025*−265.18 (−1 068.35, 537.98).518
 Model 21 (ref)669.83 (115.76, 1 223.90).038*−222.85 (−1 031.98, 586.28).668
 Model 31 (ref)548.10 (−2.36, 1 098.57).097−277.00 (−1 080.52, 526.52).564
Volume of hippocampus (n = 40 126)
 Model 11 (ref)−123.71 (−195.58, −51.83).001*52.60 (−50.37, 155.56).317
 Model 21 (ref)−117.92 (−189.70, −46.14).002*45.00 (−58.91, 148.90).481
 Model 31 (ref)−95.25 (−165.31, −25.19).014*48.67 (−52.70, 150.04).429
Volume of thalamus (n = 40 126)
 Model 11 (ref)−114.05 (−224.84, −3.26).055−12.71 (−171.43, 146.01).875
 Model 21 (ref)−101.50 (−211.52, 8.52).100−42.59 (−201.85, 116.67).680
 Model 31 (ref)−56.14 (−160.66, 48.37).362−33.85 (−185.09, 117.38).687
Volume of caudate (n = 40 126)
 Model 11 (ref)9.81 (−59.74, 79.35).78263.71 (−35.93, 163.34).263
 Model 21 (ref)12.48 (−56.88, 81.83).72445.85 (−54.55, 146.25).573
 Model 31 (ref)19.79 (−49.24, 88.81).67948.49 (−51.38, 148.37).522
Volume of putamen (n = 40 126)
 Model 11 (ref)−90.12 (−176.46, −3.78).051−22.56 (−146.25, 101.13).721
 Model 21 (ref)−83.25 (−169.32, 2.83).090−36.97 (−161.57, 87.63).596
 Model 31 (ref)−59.93 (−143.44, 23.58).255−32.68 (−153.51, 88.16).704
Volume of pallidum (n = 40 126)
 Model 11 (ref)−41.17 (−79.07, −3.28).041*17.65 (−36.63, 71.94).524
 Model 21 (ref)−39.85 (−77.67, −2.02).0669.83 (−44.92, 64.58).796
 Model 31 (ref)−29.90 (−67.25, 7.46).19012.68 (−41.37, 66.73).699
Volume of amygdala (n = 40 126)
 Model 11 (ref)−57.11 (−93.34, −20.88).003*−17.05 (−68.95, 34.86).520
 Model 21 (ref)−55.48 (−91.69, −19.27).005*−19.54 (−71.96, 32.87).608
 Model 31 (ref)−51.85 (−88.02, −15.68).012*−19.41 (−71.75, 32.92).578
Volume of accumbens (n = 40 126)
 Model 11 (ref)−24.77 (−41.11, −8.43).004*−4.71 (−28.11, 18.70).694
 Model 21 (ref)−22.35 (−38.67, −6.03).012*−2.21 (−25.83, 21.42).885
 Model 31 (ref)−15.78 (−31.33, −0.23).087−0.98 (−23.48, 21.52).932

Notes: BMI = body mass index; CI = confidence interval; CRP = C-reactive protein; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; TDI = Townsend deprivation index; TG = triglycerides. Model 1 was adjusted for age and sex. Model 2 additionally adjusted for BMI, TDI, education, ethnicity, assessment center, healthy diet, iron supplementation, smoking, and alcohol. Model 3 was based on Model 2 and additionally adjusted for the history of hypertension, cardiovascular disease, diabetes, stroke, and the levels of TG, HDL-C, LDL-C, and CRP. When assessing white matter hyperintensities and subcortical volumes, Model 3 additionally adjusted for the total intracranial volume (the sum of gray matter, white matter, and cerebrospinal fluid).

*Represent significant associations (p < .05).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close